F-α-DDB-derivative, a novel synthetic of bifendate, plus epirubicin improves antitumor efficacy against triple negative breast cancer without additional cardiotoxicity.

F-α-DDB 衍生物，一种新型的联苯酯合成物，与表柔比星联合使用可提高对三阴性乳腺癌的抗肿瘤疗效，且不会增加心脏毒性